Pharmafile Logo
Pharmafocus logo
Advanced Search

Catherine Warne made chief executive at Red Door

April 6, 2010
Medical Communications Creston, Red Door, appointment, medical communications

Red Door has made Catherine Warne chief executive as part of a reorganisation that also sees promotions for Catherine Oliver, …

Appointment
Pfizer payments

Pfizer first to disclose trial payments

April 1, 2010
Research and Development, Sales and Marketing Pfizer, industry reputation, payments

Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …

News

Roche’s Xeloda widens licence

April 1, 2010
Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer

Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …

News

Historic US reforms favour pharma – for now at least

April 1, 2010
Sales and Marketing Obama, US healthcare

The industry will be grateful for some certainty on the future market outlook and, overall, there is a strong belief …

Feature

New CRO Celerion rises out of MDS divestment

April 1, 2010
Research and Development Celerion, mds

Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …

News

Sanofi refocuses its French manufacturing capacity

April 1, 2010
Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics

Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …

News

Chiltern Announces Investment in Endpoint

April 1, 2010
Research and Development

Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to invest in Endpoint is representative of our commitment to seek collaborations which …

News
Press release

PAN makes board promotions

April 1, 2010
Medical Communications Creston, Pan, appointment, medical communications

PAN Advertising has promoted Ben Davies (pictured right) to chief executive as part of a trio of promotions within its …

Appointment

Healthcare reform momentus for pharma too

April 1, 2010
Obama, US, biosimilars, healthcare reform

Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …

News

GSK signs RNA therapeutics alliance

March 31, 2010
Research and Development GlaxoSmithKline, Isis, RNA

GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …

News

Generic substitution will not deliver significant NHS savings, says EMIG

March 31, 2010
Sales and Marketing EMIG, NHS, generics

The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …

News

Boehringer enters the venture capital business

March 31, 2010
Research and Development, Sales and Marketing Boehringer, funding, venture capital

Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …

News

EMA calls for generic clopidogrel recall

March 31, 2010
Manufacturing and Production Plavix, clopidogrel

Problems at a manufacturing facility in India have resulted in eight generic version of the antiplatelet agent clopidogrel being recalled …

News

Lilly expands trial supply deal with Thermo

March 31, 2010
Manufacturing and Production, Research and Development Thermo Fisher Scientifitic, lilly

Eli Lilly has expanded a clinical trial materials supply agreement with Thermo Fisher Scientific in yet another deal that sees …

News
WebMD Health Exchange

Digital Pharma: Byte-sized roundup

March 30, 2010
Medical Communications digital pharma

This week’s roundup of digital developments includes GSK in the new UK web archive, WebMD launches social networking site, Boehringer …

News

German price cuts denounced by industry

March 30, 2010
Sales and Marketing Germany, IQWIG

Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …

News

NICE changes its mind on Multaq

March 30, 2010
Sales and Marketing Multaq, NICE, Sanofi-Aventis

NICE has given preliminary approval of Sanofi-Aventis’ Multaq for the management of patients with atrial fibrillation. The decision reverses an …

News
Red Square

Russia debates pharma reform

March 30, 2010
Sales and Marketing Russia, em, emerging markets

The US is not the only country in the throes of passing significant legislation on major health issues.A bill has …

News

Cordis appoints Christian Spaulding

March 30, 2010
Cordis, Johnson & Johnson, appointment, research and development

Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs. He assumes the …

Appointment

Contract research news in brief

March 30, 2010
Research and Development CRO, Kendle

This week’s round-up of news in the contract research arena includes a fundraising for Irish CRO Venn Life Sciences, ISO …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025